
U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug By Reuters
© Reuters. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S., March 9, 2020. REUTERS/Brian Snyder/File Photo By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. Food and Drug Administration failed to adhere […]